Candel Therapeutics, Inc.
CADL· Nasdaq
Released May 13, 2025, before the open
10-Q filed May 13, 2025, 43 days after period end · 0000950170-25-069833
| Metric | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 |
|---|---|---|---|---|
| Revenue | — | — | — | $31.00K |
| Net Income | $7.38M | -$8.22M | -$8.80M | -$874.00K |
| EPS Diluted |
Candel Therapeutics, Inc. · CIK 1841387 · Engraved from SEC EDGAR
| $0.13 |
| -$0.28 |
| -$0.30 |
| -$0.03 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.